Introduction
developed. More importantly, chemical modification can Gene therapy has become one of the fastest developing be manipulated according to specific needs. For example, fields of biomedicine in recent years. 1 Successful gene stability of the gene could be improved by incorporating transfer depends on the use of a proper vehicle, or vector, phosphorothioate to the ends of synthetic genes. Tarwhich ideally should be highly efficient but not immunogeting ligands may also be linked to the synthetic genes genic or cytotoxic. Accordingly, much effort has recently for site-specific delivery. These potential advantages are been devoted to the improvement of delivery vehicles. 2 not shared by conventional plasmid DNA. Eventually, Less attention, however, has been paid to the problems gene therapy might be accomplished by using polydeassociated with the genes to be delivered. Plasmid DNA oxynucleotides encoding a therapeutic gene. This study is purified from bacteria. Although much progress has is designed to address the above issues by using PCR been made in the purification process, the existing proamplified, linear DNA fragments as a model for the cedure is relatively cumbersome and not cost effective.
double stranded DNA which is to be obtained by total Additionally, contamination by endotoxin remains probsynthesis. Data obtained thus far indicate that this lematic. 3 Humans and most primates are highly sensitive approach is both feasible and significant. to endotoxin. 4, 5 High doses can cause circulatory collapse in man; 6 therefore, endotoxin contamination of plasmid
Results and discussion
DNA has become an important safety concern for human gene therapy. Furthermore, endotoxin can severely It has been shown previously that linear plasmid DNA decrease the transgene expression in the transfected cells microinjected into cultured mammalian cells gave a (unpublished data). Transfection activity of DNA may higher homologous recombination frequency than that of vary from batch to batch due to various degrees of endosupercoiled molecules. 7 However, microinjection is not toxin contamination (unpublished data). Therefore, propractical in most cases for in vivo gene therapy and direct duction of DNA with reproducible purity and biological application of linear DNA for gene transfer has been activity continues to be a major obstacle in efficient gene unsuccessful. 8 In this study, two different types of PCR transfer. These problems might be solved by the use of amplified fragments, fCMV-CAT and fT7-CAT (Figure 1 ), synthetic genes, ie DNA synthesized chemically. There were used to test the feasibility of using synthetic genes are additional advantages in using synthetic genes. First, for gene therapy with liposomes as a delivery vehicle. They represented a nuclear gene expression system and a cytoplasmic gene expression system, respectively. A detailed description of the latter gene expression system a bacteriophage T7 promoter and its corresponding RNA mic expression system was also compared with that of the nuclear expression system. To make the comparison of the two systems straightforward, a cell line (293-T7) which produces endogenous T7 RNA polymerase was employed. The results are shown in Figure 2 . Strong CAT gene expression was found in cells transfected with fT7-CAT if delivered by DC-chol:DOPE liposomes. The level of expression was similar to that of pT7-CAT and also that of a nuclear expression plasmid pUCCMV-CAT delivered by DC-chol:DOPE liposomes. Very limited expression was obtained for fCMV-CAT delivered by DC-chol:DOPE liposomes or LPD complex when compared with pCMV-CAT on a molar basis. However, the CAT expression with fCMV-CAT was one third to approximately a half of that with pCMV-CAT when compared on a weight basis (1 g of DNA) (data not shown).
There are many possible reasons for the lower expression of fCMV-CAT, one of which being its linear structure. Linear DNA complexed with cationic lipids or polymers might be less efficiently transported to the nucleus or transcribed in the nucleus. Figure 2 also demonstrates that CAT activity was less for pT7-CAT and further less for fT7-CAT if they were delivered by LPD rather than by DC-chol:DOPE liposomes. This might be due to overcondensation of DNA by polycations. Particularly, linear DNA may be more condensed due to the lack of structural constraints seen with supercoiled DNA. Highly condensed DNA, as fT7-CAT condensed by polylysine in the LPD complex, probably does not allow efficient un-coating of DNA in the cytoplasm for transcription. This was indirectly confirmed in an in vitro transcription assay ( Figure 3 ). pT7-CAT showed little difference in its transcription before and after complexation with DC-chol:-DOPE liposomes. However, transcription efficiency of fT7-CAT decreased greatly after its interaction with DC- polymerase and is independent of host endogenous transcriptional machinery. The T7 RNA polymerase remains primarily in the cytoplasm owing to its lack of a nuclear localization signal; 11 therefore, nuclear transport of the plasmid DNA is not necessary. Rapid and transient expression of a CAT reporter gene, pT7-CAT, has been previously demonstrated following co-delivery with purified T7 RNA polymerase.
9 When pT7-CAT was codelivered with an enzyme regeneration system, pT7-AUTO 2C
− autogene, along with the purified enzyme, strong and sustained CAT expression was achieved, which was greater than that seen with pUCSV2CAT, a nuclear expression system.
12 Both cytoplasmic gene expression system and nuclear gene expression system have been used to express molecules with pharmacological activity. fT7-CAT by T7 RNA polymerase. It was suggested by a recent study 13 that DNA and lipid must dissociate before transcription can occur in the nucleus. Data in this study imply that T7-CAT DNA does not necessarily have to dissociate from cationic lipids in the cytoplasm; however, favorable conformation of the complex is necessary for accessibility to T7 RNA polymerase. fT7-CAT differed from pT7-CAT in its requirements for a delivery vehicle. Rules for the optimization of delivery vehicles for the plasmid DNA may not necessarily apply to the linear DNA.
While transfection efficiency of linear DNA could be optimized for both the cytoplasmic expression system and nuclear expression system, data from the above experiment suggest that gene transfer with unmodified linear DNA works better with a cytoplasmic expression system, ie fT7-CAT rather than the nuclear expression system, ie fCMV-CAT. Therefore, the gene transfer potential of synthetic genes was further investigated by focusing on the cytoplasmic expression system. Figure 4 shows the expression of the CAT reporter gene as a function of DNA concentration. The CAT continuous increases in the amount of T7-CAT might be due to, among other factors, the amount of T7 RNA polymerase produced in 293-T7 cells. Because overexpression level. This duration of CAT expression is longer than that seen with the nuclear expression system which is usually of T7 RNA polymerase is toxic to the cells, 12 probably only those 293-T7 cells which produce moderate amounts 3-5 days. 12 This might be due to the fact that some of the T7-CAT remained associated with liposomes following of enzyme could survive the selection after cotransfection. No significant difference was found between release into the cytoplasm. This could prevent DNA from rapid degradation by cytoplasmic enzymes allowing for pT7-CAT and fT7-CAT when they were delivered by liposomes.
sustained gene expression. No significant difference in CAT activity was found between pT7-CAT and fT7-CAT, Figure 5 demonstrates the expression of CAT reporter gene as a function of time. CAT expression was apparent suggesting that linear DNA fragment delivered to the cells is not necessarily degraded more rapidly than plasat 1 day following the transfection. The CAT activity peaked at day 5 and declined slowly thereafter. The level mid DNA when cationic liposomes were used as a vector.
It should be noted that a sharp increase in gene of expression at day 9 was about a quarter of the peak expression occurred following cell splitting. Such a Transfection with 293 cells After demonstrating the feasibility of using fT7-CAT, the a A mixture of either two plasmids (1 g pT 7-CAT and 0.3 g pCMV/T7-T 7pol) or two PCR fragments (1 g f T 7-CAT and efficiency of this approach was then assessed using nor- ments (data not shown). Toxicity was also noticed, which is in sharp contrast to the high CAT activity with minimal toxicity seen with 293-T7 cells. This might be due to exogenous T7 RNA polymerase being more toxic to cells expression on 293 cells showed a similar picture to that than the enzyme produced endogenously. Thus, an autoof 293-T7 cells (data not shown). gene, pCMV/T7-T7pol (Figure 1 ), was employed in the Table 1 suggests that pCMV/T7-T7pol could be subsequent studies.
replaced by fCMV/T7-T7pol. Codelivery of two PCR pCMV/T7-T7pol is a dual expression system since the fragments into 293 cells resulted in a CAT gene T7 RNA polymerase gene is under the control of both the expression two times higher than that of codelivery of CMV and T7 promoters. Following intracellular delivery, plasmids when compared on a weight basis. Higher a small amount of the pCMV/T7-T7pol may be transactivity with fragments might be due to the fact that more ported to the nucleus for the initial expression of T7 RNA molecules of both the target gene and autogene were polymerase. Once the enzyme is produced, the autogene delivered to the cells owing to the relatively smaller size could further amplify its expression via the T7 promoter of PCR fragments. and drive the synthesis of the transgene products in Last and more important, is the finding that a PCR the cytoplasm. fragment containing phosphorothioate linkage was As shown in Figure 6 , higher expression of CAT was essentially as active as the normal PCR fragment (Table  indeed obtained when the autogene was codelivered 2). Phosphorothioate modification has been used solely with T7-CAT. The expression of CAT activity increased in synthetic oligodeoxynucleotides to improve their stabsteadily with increasing pCMV/T7-T7pol. The transfecility. Therefore, inclusion of phosphorothioate linkages in tion efficiency of pT7-CAT was comparable to that of fT7-the linear PCR fragment would mimick a synthetic gene. CAT. No toxicity was noticed at any molar ratios examThough the phosphorothioate linkages were too few to ined if the cell confluence was above 70% at the time of see a clear beneficial effect, this study did suggest that transfection. However, at low cell confluency, toxicity gene therapy using a chemically modified synthetic gene was noticed if the molar ratio was above one-third.
is feasible. Further studies examining the duration of gene
We are aware of the fact that PCR fragment could be contaminated with endotoxin since Taq polymerase comes from bacteria. It has been shown that endotoxin can severely decrease the transgene expression in the transfected cells. Therefore, the efficiency of a synthetic gene approach might be underestimated by using a PCR fragment as a model. With synthetic genes, endotoxin would not be a problem. Also, synthetic genes are not associated with the problem of mutation which could size-exclusion filter. Similarly, fT7-CAT containing phosphorothioate linkage were amplified using two occur in PCR.
14 The existing problem with synthetic genes would be its high cost. However, considering the phosphodiester/phosphorothioate copolymers as primers (shown in Figure 1 ). For PCR of pCMV/T7-T7pol, rapid reduction in the cost of antisense oligodeoxynucleotides, the problem of cost for synthetic genes might be a 50°C annealing temperature was used and specific fragment was further separated from other fragments by gel solved in the near future.
In summary, we have demonstrated with 293 cells that purification following the purification procedure as mentioned above. transfection with linear DNA is both feasible and efficient. Preliminary studies showed that other types of Preparation of LPD complex cell lines could also be efficiently transfected with linear LPD complex was prepared before transfection by mixing DNA given a suitable delivery vehicle. This makes gene pH-sensitive liposomes containing CHEMS and DOPE therapy with synthetic genes a more practical approach and the cationic DNA-polylysine (1:0.75, w/w) complex worthy of further exploration. according to the method described by Lee and Huang. 19 The lipid to DNA ratio in the final LPD complex was 5:1
Materials and methods
(w/w). The resulting LPD complex was cationic in charge. The molecular weight of polylysine was 25 600.
Materials
Tissue culture T7 RNA polymerase (New England Biolabs, Beverly, MA, Human embryonic kidney 293 cells, which were rou-USA) was used without further purification. All the tinely tested and found to be free of Mycoplasma, were chemicals for PCR including Taq polymerase, nucleotides cultured in DMEM medium supplemented with 10% fetal and buffer were purchased from Gibco BRL bovine serum, penicillin (200 units/ml) and streptomycin (Gaithersburg, MD, USA). Acetyl-coenzyme A, chloram-(100 g/ml) in a humidified atmosphere with 5% CO 2 phenicol, Triton X-100 were from Sigma (St Louis, MO, at 37°C. USA). (as a source of T7 RNA polymerase) was codelivered pT7-CAT which is the same as pT7-EMC-CAT, an with T7-CAT (plasmid or PCR fragment). Four hours folexpression plasmid of the CAT gene under the control of lowing the transfection, the medium was replaced with the bacteriophage T7 promoter 16 was a kind gift from Dr normal growth medium, and cells were cultured for 2 B Moss (NIH, Bethesda, MD, USA). Plasmid pUCCMVdays before CAT assays were performed. For the time CAT was constructed in this laboratory by Dr H Farcourse study, cells were collected daily for 9 days. Cells hood. 17 pCMV/T7-T7pol, an autogene composed of the were split 1:1 once on day 4 when they were 100% T7 RNA polymerase gene under the control of both CMV confluent. and T7 promoters, was constructed in this laboratory by Dr JP Yang. A HindIII-BamHI fragment from pAR3126 H acetyl-CoA ure 1. All the plasmids were amplified in E. coli and purfor the assay mixture. The reaction was performed at ified by the CsCl gradient method. 18 For PCR of pT7-CAT 37°C for 1 h, followed by extraction with 1 ml toluene. and pCMV-CAT, 10 ng of plasmid template, 50 pmol of One half of the organic phase was mixed with 3 ml Betaeach primer (shown in Figure 1 ), 0.2 mm dNTPs, and 2.5
Max and counted for radioactivity. One unit was defined units of Thermus aquaticus (Taq) DNA polymerase were as the amount of enzyme converting 1 nmol of acetyl used. The PCR protocol consists of 4 min of denaturation groups to chloramphenicol per min under the above reacat 94°C, then 30 cycles of 45 s at 94°C, 1 min at 68°C, and tion conditions. 2 min at 72°C and finally extension for 5 min at 72°C. The resulting PCR amplified fragments were extracted with
In vitro transcription In vitro transcription was performed according to the phenol-chloroform, ethanol-precipitated, resuspended in water and then further purified by passing thorough a manufacturer (New England Biolabs). As the template,
